Resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major trauma and uncontrolled haemorrhagic shock: a systematic review with meta-analysis.

Systematic review, Resuscitative Endovascular Balloon Occlusion of the Aorta, Major trauma haemorrhage, Resuscitative thoracotomy

Journal

World journal of emergency surgery : WJES
ISSN: 1749-7922
Titre abrégé: World J Emerg Surg
Pays: England
ID NLM: 101266603

Informations de publication

Date de publication:
12 08 2021
Historique:
received: 25 05 2021
accepted: 26 07 2021
entrez: 13 8 2021
pubmed: 14 8 2021
medline: 30 9 2021
Statut: epublish

Résumé

Multiple studies regarding the use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in patients with non-compressible torso injuries and uncontrolled haemorrhagic shock were recently published. To date, the clinical evidence of the efficacy of REBOA is still debated. We aimed to conduct a systematic review assessing the clinical efficacy and safety of REBOA in patients with major trauma and uncontrolled haemorrhagic shock. We systematically searched MEDLINE (PubMed), EMBASE and CENTRAL up to June 2020. All randomized controlled trials and observational studies that investigated the use of REBOA compared to resuscitative thoracotomy (RT) with/without REBOA or no-REBOA were eligible. We followed the PRISMA and MOOSE guidelines. Two authors independently extracted data and appraised the risk of bias of included studies. Effect sizes were pooled in a meta-analysis using random-effects models. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation methodology. Primary outcomes were mortality, volume of infused blood components, health-related quality of life, time to haemorrhage control and any adverse effects. Secondary outcomes were improvement in haemodynamic status and failure/success of REBOA technique. We included 11 studies (5866 participants) ranging from fair to good quality. REBOA was associated with lower mortality when compared to RT (aOR 0.38; 95% CI 0.20-0.74), whereas no difference was observed when REBOA was compared to no-REBOA (aOR 1.40; 95% CI 0.79-2.46). No significant difference in health-related quality of life between REBOA and RT (p = 0.766). The most commonly reported complications were amputation, haematoma and pseudoaneurysm. Sparse data and heterogeneity of reporting for all other outcomes prevented any estimate. Our findings on overall mortality suggest a positive effect of REBOA among non-compressible torso injuries when compared to RT but no differences compared to no-REBOA. Variability in indications and patient characteristics prevents any conclusion deserving further investigation. REBOA should be promoted in specific training programs in an experimental setting in order to test its effectiveness and a randomized trial should be planned.

Sections du résumé

BACKGROUND
Multiple studies regarding the use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in patients with non-compressible torso injuries and uncontrolled haemorrhagic shock were recently published. To date, the clinical evidence of the efficacy of REBOA is still debated. We aimed to conduct a systematic review assessing the clinical efficacy and safety of REBOA in patients with major trauma and uncontrolled haemorrhagic shock.
METHODS
We systematically searched MEDLINE (PubMed), EMBASE and CENTRAL up to June 2020. All randomized controlled trials and observational studies that investigated the use of REBOA compared to resuscitative thoracotomy (RT) with/without REBOA or no-REBOA were eligible. We followed the PRISMA and MOOSE guidelines. Two authors independently extracted data and appraised the risk of bias of included studies. Effect sizes were pooled in a meta-analysis using random-effects models. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation methodology. Primary outcomes were mortality, volume of infused blood components, health-related quality of life, time to haemorrhage control and any adverse effects. Secondary outcomes were improvement in haemodynamic status and failure/success of REBOA technique.
RESULTS
We included 11 studies (5866 participants) ranging from fair to good quality. REBOA was associated with lower mortality when compared to RT (aOR 0.38; 95% CI 0.20-0.74), whereas no difference was observed when REBOA was compared to no-REBOA (aOR 1.40; 95% CI 0.79-2.46). No significant difference in health-related quality of life between REBOA and RT (p = 0.766). The most commonly reported complications were amputation, haematoma and pseudoaneurysm. Sparse data and heterogeneity of reporting for all other outcomes prevented any estimate.
CONCLUSIONS
Our findings on overall mortality suggest a positive effect of REBOA among non-compressible torso injuries when compared to RT but no differences compared to no-REBOA. Variability in indications and patient characteristics prevents any conclusion deserving further investigation. REBOA should be promoted in specific training programs in an experimental setting in order to test its effectiveness and a randomized trial should be planned.

Identifiants

pubmed: 34384452
doi: 10.1186/s13017-021-00386-9
pii: 10.1186/s13017-021-00386-9
pmc: PMC8358549
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

41

Investigateurs

Nino Stocchetti (N)
Elvio De Blasio (E)
Gaddo Flego (G)
Massimo Geraci (M)
Giulio Maccauro (G)
Antonio Rampoldi (A)
Federico Santolini (F)
Claudio Tacconi (C)
Gregorio Tugnoli (G)

Informations de copyright

© 2021. The Author(s).

Références

Trauma. 2019 Jan;21(1):45-54
pubmed: 30886535
J Trauma Acute Care Surg. 2016 Sep;81(3):409-19
pubmed: 27050883
J Endovasc Resusc Trauma Manag. 2020;4(1):21-29
pubmed: 32587666
Emerg Med Australas. 2020 Feb;32(1):127-134
pubmed: 31867879
Arch Dis Child. 2005 Aug;90(8):840-4
pubmed: 16040885
J Trauma Acute Care Surg. 2020 Aug;89(2):311-319
pubmed: 32345890
J Trauma Acute Care Surg. 2019 Feb;86(2):337-343
pubmed: 30694985
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Crit Care. 2016 Dec 15;20(1):400
pubmed: 27978846
Trauma Surg Acute Care Open. 2019 Sep 20;4(1):e000376
pubmed: 31673635
Scand J Trauma Resusc Emerg Med. 2021 May 17;29(1):65
pubmed: 34001219
Anesth Analg. 2017 Sep;125(3):891-894
pubmed: 28640785
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
Injury. 2020 Feb;51(2):147-156
pubmed: 31810637
J Trauma Acute Care Surg. 2015 May;78(5):1054-8
pubmed: 25909430
JAMA Surg. 2019 Jun 1;154(6):500-508
pubmed: 30892574
J Clin Epidemiol. 2017 Jan;81:101-110
pubmed: 27713072
Shock. 2020 Aug;54(2):218-223
pubmed: 31851119
World J Emerg Surg. 2017 Aug 29;12:42
pubmed: 28855960
J Trauma. 1993 Sep;35(3):375-82; discussion 382-3
pubmed: 8371295
World J Emerg Surg. 2017 Jul 14;12:30
pubmed: 28725258
Mil Med. 2018 Sep 1;183(suppl_2):55-59
pubmed: 30189087
Am J Surg. 2019 Dec;218(6):1162-1168
pubmed: 31540683
J Trauma Acute Care Surg. 2015 Oct;79(4):523-30; discussion 530-2
pubmed: 26402524
J Trauma Acute Care Surg. 2017 May;82(5):910-914
pubmed: 28430760
BJOG. 2018 Dec;125(13):1716
pubmed: 29916205
Trauma Surg Acute Care Open. 2019 Nov 11;4(1):e000340
pubmed: 31799415
PLoS One. 2016 Jan 14;11(1):e0145963
pubmed: 26766574
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S97-103
pubmed: 23778519
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Scand J Surg. 2014 Apr 15;103(2):112-119
pubmed: 24737851
J Am Coll Emerg Physicians Open. 2020 Aug 30;1(5):737-743
pubmed: 33145513
Eur J Emerg Med. 2018 Oct;25(5):348-354
pubmed: 28328730
J Trauma Acute Care Surg. 2020 May;88(5):597-606
pubmed: 32317576
Crit Care Clin. 2017 Jan;33(1):55-70
pubmed: 27894499
Eur J Trauma Emerg Surg. 2018 Aug;44(4):535-550
pubmed: 29785654
Front Vet Sci. 2019 Jun 19;6:197
pubmed: 31275952
J Trauma Acute Care Surg. 2015 May;78(5):897-903; discussion 904
pubmed: 25909407
Eur J Trauma Emerg Surg. 2020 Apr 16;:
pubmed: 32300850
J Trauma Acute Care Surg. 2015 Apr;78(4):721-8
pubmed: 25742248
J Trauma Acute Care Surg. 2016 Apr;80(4):559-66; discussion 566-7
pubmed: 26808039
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Trauma Acute Care Surg. 2016 Feb;80(2):324-34
pubmed: 26816219
Resuscitation. 2019 Feb;135:6-13
pubmed: 30594600
J Trauma Acute Care Surg. 2018 Sep;85(3):626-634
pubmed: 29787536
J Am Coll Surg. 2018 May;226(5):730-740
pubmed: 29421694
Injury. 2016 Dec;47(12):2603-2605
pubmed: 27817883

Auteurs

Greta Castellini (G)

IRCCS Istituto Ortopedico Galeazzi, Unit of Clinical Epidemiology, Milan, Italy.

Silvia Gianola (S)

IRCCS Istituto Ortopedico Galeazzi, Unit of Clinical Epidemiology, Milan, Italy. silvia.gianola@grupposandonato.it.

Annalisa Biffi (A)

National Centre for Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.

Gloria Porcu (G)

National Centre for Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.

Andrea Fabbri (A)

Emergency Department, AUSL della Romagna, Forlì, Italy.

Maria Pia Ruggieri (MP)

Emergency Department, AO San Giovanni Addolorata, Rome, Italy.

Carlo Coniglio (C)

Department of Anesthesiology, Intensive Care and Pre-Hospital Emergency Services, Maggiore Hospital Carlo Alberto Pizzardi, Bologna, Italy.

Antonello Napoletano (A)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Daniela Coclite (D)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Daniela D'Angelo (D)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Alice Josephine Fauci (AJ)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Laura Iacorossi (L)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Roberto Latina (R)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Katia Salomone (K)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Shailvi Gupta (S)

University of Maryland, Adams Cowley Shock Trauma Center, Baltimore, MD, USA.

Primiano Iannone (P)

Istituto Superiore di Sanità, Centro Eccellenza Clinica, Qualità e Sicurezza delle Cure, Rome, Italy.

Osvaldo Chiara (O)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
General Surgery and Trauma Team, ASST Grande Ospedale Metropolitano Niguarda, University of Milan, Milano, Piazza Ospedale Maggiore, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH